Abbott → AbbVie: One of the Most Successful Spin-offs Ever
In 2013, a healthy Abbott proactively spun off its pure-pharma business as AbbVie. This analysis explains why two risk profiles need two kinds of shareholders and how AbbVie used post-spin capital autonomy to defuse the Humira patent cliff.
